OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
20
Results
Show all
Save search
Copy query
Show results for
Unknown
(20)
Publication Date
Release Date
2023
(5)
2022
(5)
2021
(4)
2018
(3)
2011
(2)
2013
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Aerosol precautions and airway complications: a national prospective multicentre cohort study.
Not available
S-EPMC10087829
|
biostudies-literature
Cite
COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study.
Not available
S-EPMC9240087
|
biostudies-literature
Cite
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
Not available
S-EPMC10436185
|
biostudies-literature
Cite
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
Not available
S-EPMC9634600
|
biostudies-literature
Cite
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers.
Not available
S-EPMC7781098
|
biostudies-literature
Cite
The Duration, Dynamics, and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Responses in Individual Healthcare Workers.
Not available
S-EPMC7929225
|
biostudies-literature
Cite
Results of the two incidence screenings in the National Lung Screening Trial.
Not available
S-EPMC4307922
|
biostudies-literature
Cite
Reduced lung-cancer mortality with low-dose computed tomographic screening.
Not available
S-EPMC4356534
|
biostudies-literature
Cite
Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes.
Not available
S-EPMC9997060
|
biostudies-literature
Cite
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells.
Not available
S-EPMC8552693
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets